Vision restored in 78-year-old patient following artificial cornea implantation
A previously blind Israeli man was able to read and recognise family members following the successful surgery
Surgery to implant the CorNeat KPro artificial cornea was carried out at the Rabin Medical Center in Israel.
Professor Irit Bahar, who carried out the surgery, highlighted that the results of the operation had “exceeded all of our expectations.”
“Moments like these are the fulfillment of our calling as doctors. We are proud of being at the forefront of this exciting and meaningful project, which will undoubtedly impact the lives of millions," he said.
The operation was the first time that the artificial cornea has been implanted in a patient.
A total of 10 Israeli patients will receive the surgery as part of a broader multi-national clinical trial aimed at securing regulatory approval for the device within different international jurisdictions.
All patients within the Rabin Medical Center trial are either not suitable candidates for traditional corneal transplantation or have had one or more failed corneal transplantation surgeries.
The CorNeat KPro artificial cornea is made from a synthetic porous material that mimics the structure of the extracelluar matrix.
When implanted, it stimulates the proliferation of cells leading to progressive tissue integration.